Atria Investments Inc Reduces Position in Cigna Group $CI

Atria Investments Inc cut its position in Cigna Group (NYSE:CI) by 11.7% during the fourth quarter, HoldingsChannel reports. The firm owned 15,935 shares of the health services provider’s stock after selling 2,115 shares during the quarter. Atria Investments Inc’s holdings in Cigna Group were worth $4,386,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CI. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group in the 4th quarter valued at approximately $28,000. Lodestone Wealth Management LLC purchased a new stake in shares of Cigna Group in the 4th quarter valued at approximately $32,000. Collier Financial purchased a new stake in shares of Cigna Group in the 3rd quarter valued at approximately $34,000. Activest Wealth Management increased its position in shares of Cigna Group by 1,050.0% in the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the last quarter. Finally, True Wealth Design LLC grew its position in shares of Cigna Group by 116.4% in the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after buying an additional 85 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 205,904 shares of company stock worth $60,277,068. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Truist Financial increased their target price on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research report on Tuesday, February 10th. Jefferies Financial Group dropped their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Wells Fargo & Company increased their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research report on Friday, May 1st. Finally, Cantor Fitzgerald increased their target price on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $338.35.

Cigna Group Stock Down 3.3%

Shares of NYSE:CI opened at $285.25 on Friday. The stock has a market cap of $75.46 billion, a P/E ratio of 12.09, a P/E/G ratio of 1.00 and a beta of 0.30. The firm has a fifty day moving average price of $274.95 and a 200 day moving average price of $275.97. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.